IGC Pharma (IGC) Company Statistics | The Fly

Search...

/

Dashboard

Charting

KPIs

Stock Screener

ETF Screener

Earnings Calendar

Events Calendar

Syndicate

Street Research

Portfolios

Alert Settings

IGC Pharma (IGC) Company Statistics | The Fly

© 2026 The Fly Inc.

The Fly Cast

Press play to listen

©

IGC Pharma

· IGC

Dashboard

Financials

Ratios

Valuation

Statistics

27.655 M

+0.52%

General

Market Cap: $27.66M
Enterprise Value: $27.67M
Shares Outstanding: 104,370,000
Dividend: —
Employees: —
Revenue Per Employee: —

Fundamental Ratios (TTM)

Gross Margin: 21.91%
Operating Margin: -986.82%
Net Profit Margin: -702.14%
FCF Margin: -543.37%
ROA: -83.03%
ROE: -113.58%
ROIC: -153.62%
Current Ratio: 0.39
Debt-to-Equity: 0.18
Revenue Per Employee: —

Valuation (TTM)

P/E: —
PEG: —
P/S: 23.97
P/FCF: —
P/B: 4.39
EV/EBITDA: -3.72

Growth

Rev 1Y: -6.69%
Rev 1Y Fwd Est: -27.74%
Rev 3Y (CAGR): —
Rev 5Y (CAGR): 5.72%
Rev 10Y (CAGR): -15.47%
EPS 1Y: —
EPS 1Y Fwd Est: —
EPS 3Y (CAGR): —

Income Statement (TTM)

Revenue: $1.12M
Gross Margin: 21.91%
Operating Expenses: $11.33M
Operating Income: -$11.08M
Net Profit: -$7.89M

Balance Sheet

EPS 5Y (CAGR)

—

EPS 10Y (CAGR)

—

Cash and Equivalents: $331K
Working Capital: -$1.95M
Total Assets: $9.5M
Net Debt: $751K
Total Liabilities: $3.36M
Total Equity: $6.13M

Cash Flow Statement (TTM)

Cash Flow from Operations: -$5.89M
Cash Flow from Investing: -$1.03M
Cash Flow from Financing: $6.81M
Free Cash Flow: -$6.1M
Capital Expenditures: $216K